Back
Medpace Holdings Quote, Financials, Valuation and Earnings

Serious profits in months with teeny tiny gains?
Check out the details here.
Buy
60
MEDP
Medpace Holdings
Last Price:
279.52
Seasonality Move:
4.23%
7 Day Trial
ALL ACCESS PASS
$
7

The Results Are In: Bryan Perry's "Million-Dollar Beta Test"
Click here to see how these extraordinary trading gains came to pass...and find out what Bryan has planned for the rest of 2023 - his fourth and final Beta Test.Medpace Holdings Price Quote
$279.52
Medpace Holdings Key Stats
Buy
60
Medpace Holdings (MEDP)
is a Buy
Day range:
$273.14 - $280.24
52-week range:
$167.00 - $287.00
Dividend yield:
0%
P/E ratio:
38.40
P/S ratio:
5.02
P/B ratio:
18.21%
Volume:
213.8K
Avg. volume:
313.6K
1-year change:
33.74%
Market cap:
$8.6B
Revenue:
$1.5B
EPS:
$8.54
How Much Does Medpace Holdings Make?
-
How Much Are Medpace Holdings's Sales Annually?
MEDP Revenues are $1.5B -
How Much Profit Does Medpace Holdings's Make A Year?
MEDP net income is $245.4M
Is Medpace Holdings Growing As A Company?
-
What Is Medpace Holdings's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.28% -
What Is Medpace Holdings's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.08%
Medpace Holdings Stock Price Performance
-
Did Medpace Holdings Stock Go Up Last Month?
Medpace Holdings share price went up by 1.94% last month -
Did MEDP's Share Price Rise Over The Last Year?
MEDP share price rose by 33.74% over the past 1 year
What Is Medpace Holdings 52-Week High & Low?
-
What Is Medpace Holdings’s 52-Week High Share Price?
Medpace Holdings has traded as high as $287.00 over the past 52 weeks -
What Is Medpace Holdings’s 52-Week Low Share Price?
Medpace Holdings has traded as low as $167.00 over the past 52 weeks
Medpace Holdings Price To Free Cash Flow
-
Is Medpace Holdings Stock Overvalued?
Medpace Holdings is trading at a price to free cash flow ratio of 23.66 -
Is Medpace Holdings Stock Undervalued?
Medpace Holdings EV to Free Cash Flow ratio is 22.45 -
What Is Medpace Holdings’s Price Earnings Growth Ratio?
MEDP PEG ratio is 1.06 -
Is Medpace Holdings Trading At A Premium To Earnings?
Medpace Holdings EV to EBIT ratio is 27.01
Is It Risky To Buy Medpace Holdings?
-
How Much Debt Does Medpace Holdings Have?
Total long term debt quarterly is $0 -
How Much Cash Does Medpace Holdings Have?
Cash and short term investments quarterly total is $95.2M -
What Is Medpace Holdings’s Book Value Per Share?
Book value per share is 15.35
Is Medpace Holdings Cash Flow Positive?
-
What Is MEDP Cash Flow From Operations?
Cash flow from operations (TTM) is $413.7M -
What Is Medpace Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$315.3M -
What Is Medpace Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$35.9M
Medpace Holdings Return On Invested Capital
-
Is Management Doing A Good Job?
MEDP return on invested capital is 59.25% -
What Is Medpace Holdings Return On Assets?
ROA measures how assets are converting to revenues and is 19.6% -
What Is MEDP Return On Equity?
ROE is a measure of profitability and is 70.21%
Medpace Holdings Earnings Date & Stock Price
-
What Is Medpace Holdings's Stock Price Today?
A single share of MEDP can be purchased today for 279.52 -
What Is Medpace Holdings’s Stock Symbol?
Medpace Holdings trades on the nasdaq under the ticker symbol: MEDP -
When Is Medpace Holdings’s Next Earnings Date?
The next quarterly earnings date for Medpace Holdings is scheduled on February 13, 2024 -
When Is MEDP's next ex-dividend date?
Medpace Holdings's next ex-dividend date is December 5, 2023 -
How To Buy Medpace Holdings Stock?
You can buy Medpace Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Medpace Holdings Competitors
-
Who Are Medpace Holdings's Competitors?
Below is a list of companies who compete with Medpace Holdings or are related in some way:
Medpace Holdings Dividend Yield
Data Unavailable
Medpace Holdings Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 8.29% | 2.1% |
Revenue: | 28.34% | 3.52% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 278.60 |
Downside from Last Price: | -0.33% |